AusPAR: Semaglutide

Australian Public Assessment Report

AusPAR

AusPAR: Semaglutide [PDF, 315.83 KB]

AusPAR: Semaglutide [Word, 402.25 KB]

Attachment: Product Information for Semaglutide [PDF, 481.54 KB]

Attachment: Product Information for Semaglutide [Word, 1.75 MB]

Device/Product Name

Ozempic

Active ingredients

Semaglutide

AusPAR Date

30 October 2020

Published

2 December 2020

Submission Number

PM-2018-02748-1-5

Submission Type

New biological entity

Decision

Approved